Finding cost-effective ways to prevent heart disease in people with HIV
Cost-effectiveness of cardiovascular disease prevention in HIV care: a systems science approach
This study is looking at how to help people with HIV make lifestyle changes to keep their hearts healthy and prevent heart disease, and it aims to find the best ways to do this in healthcare settings while keeping costs in mind.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Trustees of Indiana University NIH-funded |
| Lab location | 1 site (Bloomington, United States) |
| Project ID | NIH-10661850 on NIH RePORTER |
What this research studies
This research investigates how to effectively integrate lifestyle modification strategies into HIV care to prevent cardiovascular disease (CVD), which disproportionately affects individuals living with HIV. It aims to identify the necessary processes and structures for delivering these interventions, estimate their costs, and determine the best ways to implement them in existing healthcare systems. Using a novel approach called agent-based modeling, the study will analyze various intervention strategies to find the most cost-effective solutions for improving heart health among HIV patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are at risk for cardiovascular disease.
Not a fit: Patients who do not have HIV or those who are not at risk for cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cardiovascular health and reduced disease burden for individuals living with HIV.
How similar studies have performed: Other research has shown success in integrating lifestyle modifications in chronic disease management, suggesting potential for this approach in HIV care.
Where this research is happening
Bloomington, United States
- Trustees of Indiana University — Bloomington, United States (Active)
Researchers
- Principal investigator: Galaviz, Karla Ivette — Trustees of Indiana University
- Study coordinator: Galaviz, Karla Ivette
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.